{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042964","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.410857+00:00","generated_at":"2026-05-30T07:56:26.082276+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Protagenic Therapeutics raises $1.275M in private placement of common stock and warrants","bullets":["Issued 1,948,295 shares (or pre-funded warrants) at $0.64 per share ($0.89 for insiders).","Also issued Series A warrants (18-month term) and Series B warrants (5-year term), both exercisable at $0.64.","Gross proceeds ~$1.275 million; net proceeds for working capital.","Closing expected on or before November 4, 2024; Brookline Capital Markets acted as placement agent.","Directors and officers subject to 90-day lock-up from closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042964","json":"https://secwatch.observer/filing/0001493152-24-042964.json","markdown":"https://secwatch.observer/filing/0001493152-24-042964.md","text":"https://secwatch.observer/filing/0001493152-24-042964.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224042964/0001493152-24-042964-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224042964/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:56:26.082276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}